Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OS9 antisense RNA 1 (OS9-AS1)
- Target
- OS9-AS1
- Molecular classification
- Antisense long non-coding RNA (lncRNA), Non-protein coding RNA
01
Overview
OS9 antisense RNA 1 (OS9-AS1) is a long non-coding RNA transcribed from the OS9 locus. It is classified as an antisense lncRNA because it is transcribed from the DNA strand opposite the OS9 gene. There is currently no published functional or mechanistic data specifically for OS9-AS1. However, antisense lncRNAs in general are known to regulate gene expression by forming RNA duplexes with their sense transcripts, influencing mRNA stability, splicing, or translation. OS9-AS1 is annotated in major gene databases, but its precise biological role, disease relevance, and molecular interactions remain uncharacterized. No interacting drugs, disease associations, or safety concerns are reported for this RNA at present[5][1].
02
Mechanism of action
Not applicable; there are no drugs or targeted interventions reported for OS9-AS1
03
Biological functions
Regulation of OS9 gene expression (putative, based on other antisense lncRNAs and locus proximity; direct functional data is lacking)Post-transcriptional gene regulation (general for antisense lncRNAs)
04
Disease associations
No disease associations or roles described directly for OS9-AS1. However, since neighboring gene OS9 has putative roles in cancer (primarily due to its function in endoplasmic reticulum quality control and as a putative tumor suppressor), it could be speculated that OS9-AS1 might influence these processes indirectly, but there is no direct evidence for this.
Beyond the preview
Go deeper on OS9 antisense RNA 1 (OS9-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OS9 antisense RNA 1 (OS9-AS1).